Published: 1998 Received: April 09, 1997Available on J-STAGE: April 07, 2006Accepted: July 07, 1997
Advance online publication: -
Revised: -
Correction information
Date of correction: April 07, 2006Reason for correction: -Correction: CITATIONDetails: Wrong : 1) Battistuzzi G, Petrucci R, Silvagni L, Urbani FR, Caiola S. &selta;-aminolevulinate dehydrase: a new genetic polymorphism in man. Ann Hum Genet 1981; 45: 223-229. 2) Wetmur JG, Lehnert G, Desnick RJ. The δ-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ Res 1991; 56: 109-119. 3) Smith CM, Wang X, Hu H, Kelsey KT. A polymorphism in the δ-aminolevulinic acid dehydrase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect 1995; 103: 248-253. 4) Wetmur JG, Kaya AH, Plewinska M, Desnick R. Molecular characterization of the human δ-aminolevulinate dehydratase 2 (ALAD2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning. Am J Hum Genet 1991; 49: 757-763. 5) Nikkanen J, Hernberg S, Tola S. Modifications of the δ-aminolevulinic acid dehydratase test and their significance for assessing different intensities of lead exposure. Work Environ Health 1972; 9: 46-52. 6) Tomokuni K, Ogata M. Simple method for determination of urinary δ-aminolevulinic acid as an index of lead exposure. Clin Chem 1972; 18: 1534-1536. 7) Morita Y, Sakai T, Tsuruta H, Araki T. Polymorphism of delta-aminolevulinic acid dehydratase and delta-aminolevulinic acid in plasma in lead workers and unexposed subjects. San Ei Shi 1996; 38: S500 (in Japanese). 8) Benkmann HG, Bogdanski P, Goedde HW. Polymorphism of delta-aminolevulinic acid dehydratase in various populations. Hum Hered 1983; 33: 62-64. 9) Hernberg S, Nikkanen J. δ-aminolevulinic acid dehydratase as a measure of lead exposure. Arch Environ Health 1970; 21: 140-145.
Right : 1) Battistuzzi G, Petrucci R, Silvagni L, Urbani FR, Caiola S. δ-aminolevulinate dehydrase: a new genetic polymorphism in man. Ann Hum Genet 1981; 45: 223-229. 2) Wetmur JG, Lehnert G, Desnick RJ. The δ-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ Res 1991; 56: 109-119. 3) Smith CM, Wang X, Hu H, Kelsey KT. A polymorphism in the δ-aminolevulinic acid dehydrase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect 1995; 103: 248-253. 4) Wetmur JG, Kaya AH, Plewinska M, Desnick R. Molecular characterization of the human δ-aminolevulinate dehydratase 2 (ALAD2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning. Am J Hum Genet 1991; 49: 757-763. 5) Nikkanen J, Hernberg S, Tola S. Modifications of the δ-aminolevulinic acid dehydratase test and their significance for assessing different intensities of lead exposure. Work Environ Health 1972; 9: 46-52. 6) Tomokuni K, Ogata M. Simple method for determination of urinary δ-aminolevulinic acid as an index of lead exposure. Clin Chem 1972; 18: 1534-1536. 7) Morita Y, Sakai T, Tsuruta H, Araki T. Polymorphism of delta-aminolevulinic acid dehydratase and delta-aminolevulinic acid in plasma in lead workers and unexposed subjects. San Ei Shi 1996; 38: S500 (in Japanese). 8) Benkmann HG, Bogdanski P, Goedde HW. Polymorphism of delta-aminolevulinic acid dehydratase in various populations. Hum Hered 1983; 33: 62-64. 9) Hernberg S, Nikkanen J. δ-aminolevulinic acid dehydratase as a measure of lead exposure. Arch Environ Health 1970; 21: 140-145.
Date of correction: April 07, 2006Reason for correction: -Correction: PDF FILEDetails: -